Momenta, Sandoz Push For Sanctions In Blood Clot Drug Suit

By Adam Lidgett (September 16, 2019, 5:30 PM EDT) -- Momenta and Sandoz have urged a Tennessee federal court to sanction a hospital accusing them of conspiring to monopolize the blood clot drug Lovenox and its generic version for allegedly not properly preserving certain billing records, a move the hospital called a distraction....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!